<h3>Gainers</h3>
<ul>
<li>HCW Biologics (NASDAQ:HCWB) stock increased by 126.4% to $2.4 during Wednesday's regular session. The market value of their outstanding shares is at $7.1 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Silexion Therapeutics (NASDAQ:SLXN) stock rose 77.58% to $0.48. The market value of their outstanding shares is at $1.0 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>MetaVia (NASDAQ:MTVA) stock increased by 54.78% to $2.91. The market value of their outstanding shares is at $9.7 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>BiomX (AMEX:PHGE) stock moved upwards by 36.71% to $0.51. The market value of their outstanding shares is at $3.7 million. </li>
<li>Immunovant (NASDAQ:IMVT) shares increased by 36.2% to $35.81. The market value of their outstanding shares is at $5.3 billion. As per the press release, Q4 earnings came out today. </li>
<li>Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 31.26% to $3.31. The company's market cap stands at $31.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wellgistics Health (NASDAQ:WGRX) shares decreased by 28.6% to $0.12 during Wednesday's regular session. The market value of their outstanding shares is at $21.2 million. The company's, Q1 earnings came out yesterday. </li>
<li>Sunshine Biopharma (NASDAQ:SBFM) stock decreased by 17.96% to $0.36. The market value of their outstanding shares is at $2.2 million. </li>
<li>GlucoTrack (NASDAQ:GCTK) stock declined by 16.39% to $0.46. The company's market cap stands at $2.0 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares declined by 15.0% to $0.09. </li>
<li>Lakewood-Amedex (NASDAQ:LABT) shares fell 14.61% to $0.74. The company's market cap stands at $12.4 million. </li>
<li>Purple Biotech (NASDAQ:PPBT) stock declined by 12.83% to $3.06. The market value of their outstanding shares is at $3.2 million. As per the news, the Q1 earnings report came out 3 days ago. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SLXN

HCWB

MTVA

On Wednesday, HCW Biologics surged 126.4% to $2.4, following its Q1 earnings report. Other gainers included Silexion Therapeutics (+77.58%), MetaVia (+54.78%), and Immunovant (+36.2%). Conversely, Wellgistics Health fell 28.6% to $0.12, with Sunshine Biopharma and GlucoTrack also declining significantly. The market values of these companies vary, with Immunovant holding a market cap of $5.3 billion.

benzinga_article

Silexion Therapeutics

HCW Biologics

MetaVia

Immunovant

ALPS Medical Breakthrough

VanEck Pharmaceutical ETF

Direxion S&P Biotech Bull 3X

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

VG Health

iShares Biotechnology ETF

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Ark Genomic Revolution ETF

Invesco Pharmaceuticals ETF

SPDR Pharmac

iShares US Medical Devices

SPDR S&P Health Equip

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

BiomX

Quantum Cyber NV

Wellgistics Health

Sunshine Biopharma

GlucoTrack

Lakewood-Amedex Biotherapeutics

Purple Biotech

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM)

Mainz Biomed NV

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Wednesday's Intraday Session